<?xml version="1.0" encoding="UTF-8"?>
<p>Other lipid nanostructures such as nanostructured lipid carriers (NLCs) have also been explored and have an imperfect crystalline structure that enables high drug loading [
 <xref rid="B74-molecules-25-05414" ref-type="bibr">74</xref>]. Hence, NLCs have been explored for the encapsulation of BJO by itself and in combination with other chemotherapeutic drugs for anticancer applications.
</p>
